|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 |
| (11) | Number of the document | 2593137 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11735738.4 |
| Date of filing the European patent application | 2011-07-11 | |
| (97) | Date of publication of the European application | 2013-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043511 |
| Date | 2011-07-11 |
| (87) | Number | WO 2012/009254 |
| Date | 2012-01-19 |
| (30) | Number | Date | Country code |
| 364112 P | 2010-07-14 | US |
| (72) |
WALSH, Scott, US
POTOCKY, Terra, US
DIX, Daniel, US
SIVENDRAN, Renuka, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES |
| STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES |